-Paul Horn Researcher Activity Profile

Research Author Detailed Information 

Paul Horn Publication Rate By Year

Paul Horn has published 1 paper(s) in 2001, 2 paper(s) in 2006, 11 paper(s) in 2007, 3 paper(s) in 2008, for a total of 17 research publications in total.

Paul P Horn Author Information

LAST NAME: horn

FIRST NAME: Paul

INITIALS: p

AFFILIATION:

Papers

Paul Horn's Publication Record

1. Methylphenidate and cocaine: a placebo-controlled drug interaction study. Year Published: 2006
Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA. winhusen@mdru.uc.edu
2. The future of research universities. Is the model of research-intensive universities still valid at the beginning of the twenty-first century? Year Published: 2007
3. A double-blind, placebo-controlled trial of reserpine for the treatment of cocaine dependence. Year Published: 2007
Department of Psychiatry, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267, USA. winhusen@mdru.uc.edu
4. A double-blind, placebo-controlled trial of tiagabine for the treatment of cocaine dependence. Year Published: 2007
Department of Psychiatry, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267, USA. winhusen@mdru.uc.edu
5. Complex spontaneous extracranial-intracranial collateralization in progressive systemic atherosclerotic disease. Year Published: 2007
6. Absorption, distribution and elimination of fumonisin B(1) metabolites in weaned piglets. Year Published: 2007
7. The future of research universities. Is the model of research-intensive universities still valid at the beginning of the twenty-first century? Year Published: 2007
8. Exercise-recruited NK cells display exercise-associated eHSP-70. Year Published: 2008
University of Canberra, Canberra, Australia. peggy.horn@ausport.gov.au
9. Detection of a gamma-Carboxy-Glutamate as Novel Post-Translational Modification of Human Transthyretin. Year Published: 2008
European Molecular Biology Laboratory, Proteomic Core Facility, Meyerhofstr. 1. 69117 Heidelberg, Germany. franz@embl.de.
10. Exercise-recruited NK cells display exercise-associated eHSP-70. Year Published: 2008
University of Canberra, Canberra, Australia. peggy.horn@ausport.gov.au
11. Absorption, distribution and elimination of fumonisin B(1) metabolites in weaned piglets. Year Published: 2007
Faculty of Animal Science, University of Kaposvár, H-7400 Kaposvár, Hungary. juditfodorkapos@freemail.hu
12. Xenon-induced flow activation in patients with cerebral insult who undergo xenon-enhanced CT blood flow studies. Year Published: 2001
Department of Neurosurgery, University Hospital Mannheim, Faculty of Clinical Medicine, University Heidelberg, Mannheim, Germany.
13. The SRPHK1 outcome measure for cocaine-dependence trials combines self-report, urine benzoylecgonine levels, and the concordance between the two to determine a cocaine-use status for each study day. Year Published: 2007
Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA. somoza@uc.edu
14. 2D cine phase-contrast MRI for volume flow evaluation of the brain-supplying circulation in moyamoya disease. Year Published: 2006
Department of Clinical Radiology, University of Heidelberg, Universitätsklinikum Mannheim, Theodor-Kutzer Ufer 1-3, 68167 Mannheim, Germany. wolfgang.neff@rad.ma.uni-heidelberg.de
15. A double-blind, placebo-controlled trial of reserpine for the treatment of cocaine dependence. Year Published: 2007
Department of Psychiatry, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267, USA. winhusen@mdru.uc.edu
16. A double-blind, placebo-controlled trial of tiagabine for the treatment of cocaine dependence. Year Published: 2007
Department of Psychiatry, University of Cincinnati College of Medicine, 231 Albert Sabin Way, Cincinnati, OH 45267, USA. winhusen@mdru.uc.edu
17. The SRPHK1 outcome measure for cocaine-dependence trials combines self-report, urine benzoylecgonine levels, and the concordance between the two to determine a cocaine-use status for each study day. Year Published: 2007
Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA. somoza@uc.edu